Medicure Inc. to Present at Biotechnology Industry Organization (BIO) CEO & Investor Conference

WINNIPEG, MANITOBA--(Marketwire - February 11, 2008) - Medicure Inc. (TSX: MPH)(AMEX: MCU), a cardiovascular focused biopharmaceutical company, today announced its President and CEO, Albert D. Friesen, PhD, will deliver a corporate presentation at The 10th Annual BIO CEO & Investor Conference. The presentation will take place at 2:45 p.m. Eastern Time on Wednesday, February 13th in the East Foyer at the Waldorf-Astoria Hotel in New York, NY.

MORE ON THIS TOPIC